Camp4 Therapeutics (CAMP)CFO bought ~$11K
Kelly Gold, CFO at Camp4 Therapeutics, bought ~$11K of Camp4 Therapeutics shares.
- ~$11K
- Approx. value · 6,551 sh @ $1.65
- 74K
- Holds after · shares reported
- Traded
- Aug 3, 2026
- Filed
- Aug 5, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 10, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 10, 2026, at the annual meeting of stockholders (the “Annual Meeting”) of CAMP4 Therapeutics Corporation (the “Company”), the stockholders of the Company approved an amendment to the CAMP4 Therapeutics Corporation 2024 Equity Incentive Plan (the “2024 Plan”) to amend the evergreen provision to provide that any of the Company’s outstanding pre-funded warrants shall be added to the total number of shares of…”
- Aug 3, 2026 · this disclosureInsider · 10 days before resultsCFO purchased ~$11K of CAMP shares in the open market
What came next
- Aug 3, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Aug 3, 2026Insider · 3 peopleInsiders: 3 purchases (~$49K)
- Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 19, 2026Insider · 2 peopleInsiders: 2 sales (~$223K)
- Aug 20, 2026InsiderDirector sold ~$521K of CAMP shares in the open market
- Aug 21, 2026InsiderDirector sold ~$144K of CAMP shares in the open market
- Aug 24, 2026InsiderDirector sold ~$45 of CAMP shares in the open market
- Aug 27, 2026InsiderDirector sold ~$1.62M of CAMP shares in the open market
- Aug 31, 2026InsiderCFO purchased ~$40K of CAMP shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Camp4 Therapeutics
For Camp4 Therapeutics, OQRO holds 11 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CAMP page.
Other recent filings by Kelly Gold, Chief Financial Officer
- SEC Form 4 at Camp4 Therapeutics (CAMP)Sep 2, 2026
- SEC Form 4 at Camp4 Therapeutics (CAMP)Sep 11, 2025
The full history of Kelly Gold, Chief Financial Officer is on the profile page.
How this filing works
Other disclosures at Camp4 Therapeutics
- SEC Form 4Sep 2, 2026
- SEC Form 4Aug 31, 2026
- SEC Form 4Aug 26, 2026
- SEC Form 4Aug 21, 2026
- SEC Form 4Aug 21, 2026
- SEC Form 4Aug 21, 2026
Everything OQRO holds on this company is on its CAMP page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
